European Stocks That May Be Undervalued In July 2025

As of July 2025, the European stock market has shown mixed performance with the pan-European STOXX Europe 600 Index ending roughly flat amid ongoing U.S. and European trade talks, while major indices like Italy’s FTSE MIB and the UK’s FTSE 100 have seen slight gains. In this context, identifying potentially undervalued stocks involves looking for companies that may be poised to benefit from economic indicators such as expanding eurozone industrial output and a widening trade surplus.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name	Current Price	Fair Value (Est)	Discount (Est)
Upsales Technology (OM:UPSALE)	SEK37.90	SEK75.38	49.7%
Talenom Oyj (HLSE:TNOM)	€3.50	€6.95	49.6%
RVRC Holding (OM:RVRC)	SEK45.66	SEK91.03	49.8%
KebNi (OM:KEBNI B)	SEK2.755	SEK5.44	49.3%
Green Oleo (BIT:GRN)	€0.80	€1.58	49.3%
doValue (BIT:DOV)	€2.488	€4.95	49.7%
Digital Workforce Services Oyj (HLSE:DWF)	€3.41	€6.80	49.8%
BHG Group (OM:BHG)	SEK25.04	SEK48.98	48.9%
Atea (OB:ATEA)	NOK144.00	NOK286.37	49.7%
Absolent Air Care Group (OM:ABSO)	SEK243.00	SEK482.96	49.7%

Click here to see the full list of 191 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Here we highlight a subset of our preferred stocks from the screener.

doValue (BIT:DOV)

Overview: doValue S.p.A. specializes in managing non-performing loans, unlikely to pay, early arrears, and performing loans for banks and investors across Italy, Spain, Greece, and Cyprus with a market cap of €471.69 million.

Operations: Revenue segments for doValue S.p.A. include the management of non-performing loans, unlikely to pay, early arrears, and performing loans across Italy, Spain, Greece, and Cyprus.

Estimated Discount To Fair Value: 49.7%

doValue is trading at €2.49, significantly below its estimated fair value of €4.95, indicating potential undervaluation based on discounted cash flow analysis. Despite a volatile share price and recent shareholder dilution, the company has become profitable this year with revenue expected to grow 9.9% annually, outpacing the Italian market average. Recent acquisitions and improved earnings results further bolster its position as an undervalued stock with high growth prospects in Europe.

• Our growth report here indicates doValue may be poised for an improving outlook.
• Dive into the specifics of doValue here with our thorough financial health report.

PostNL (ENXTAM:PNL)

Overview: PostNL N.V. offers postal and logistics services to businesses and consumers in the Netherlands, Europe, and internationally, with a market cap of €536.66 million.

Operations: The company's revenue is primarily derived from its Parcels segment, generating €2.39 billion, and Mail in the Netherlands, contributing €1.33 billion.

Estimated Discount To Fair Value: 38.9%

PostNL is trading at €1.06, well below its estimated fair value of €1.73, highlighting potential undervaluation based on discounted cash flow analysis. Despite high debt levels and a volatile share price, earnings are forecast to grow significantly at 32.9% annually, outpacing the Dutch market average. Recent results showed improved net losses and sales growth to €779 million in Q1 2025 compared to the previous year, underscoring its position among undervalued stocks in Europe.

• The growth report we've compiled suggests that PostNL's future prospects could be on the up.
• Click to explore a detailed breakdown of our findings in PostNL's balance sheet health report.

Vitrolife (OM:VITR)

Overview: Vitrolife AB (publ) specializes in providing assisted reproduction products across Europe, the Middle East, Africa, Asia-Pacific, and the Americas, with a market cap of SEK19.95 billion.

Operations: The company's revenue segments include Genetics at SEK1.46 billion, Consumables at SEK1.39 billion, and Technologies at SEK691 million.

Estimated Discount To Fair Value: 31.3%

Vitrolife is trading at SEK147.3, significantly below its estimated fair value of SEK214.4, suggesting potential undervaluation based on discounted cash flow analysis. Despite a recent decline in sales and net income for Q2 2025, earnings are projected to grow substantially at 22.3% annually, surpassing the Swedish market average. The company also secured a EUR 300 million loan agreement for refinancing and corporate purposes, reflecting strong credit support from Nordic banks.

• Our comprehensive growth report raises the possibility that Vitrolife is poised for substantial financial growth.
• Delve into the full analysis health report here for a deeper understanding of Vitrolife.

Seize The Opportunity

• Take a closer look at our Undervalued European Stocks Based On Cash Flows list of 191 companies by clicking here.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com